SEHK:1349Pharmaceuticals
Shanghai Fudan Zhangjiang Bio Pharmaceutical Ltd (SEHK:1349) Stock Profit Rebound Raises Durability Questions
The market went into these Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd results already leaning optimistic, with the stock up over the past month and sitting at HK$2.615 into the close on 14 August. The earnings story that dropped behind that price was all about profit quality. Q2 basic earnings per share of ¥0.028153 and net income of ¥29.18m stand out against a recent history of losses, even as the trailing twelve month figures still show the company in the red. The question now is...